These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 11942498

  • 1. Proton MR spectroscopic imaging in multiple sclerosis.
    Tedeschi G, Bonavita S, McFarland HF, Richert N, Duyn JH, Frank JA.
    Neuroradiology; 2002 Jan; 44(1):37-42. PubMed ID: 11942498
    [Abstract] [Full Text] [Related]

  • 2. Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and 1H-MRSI study.
    Auer DP, Schirmer T, Heidenreich JO, Herzog J, Pütz B, Dichgans M.
    Neurology; 2001 Mar 13; 56(5):635-42. PubMed ID: 11245716
    [Abstract] [Full Text] [Related]

  • 3. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
    Duan Y, Liu Z, Liu Y, Huang J, Ren Z, Sun Z, Chen H, Dong H, Ye J, Li K.
    Acta Radiol; 2017 Sep 13; 58(9):1132-1137. PubMed ID: 28173728
    [Abstract] [Full Text] [Related]

  • 4. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
    Husted CA, Goodin DS, Hugg JW, Maudsley AA, Tsuruda JS, de Bie SH, Fein G, Matson GB, Weiner MW.
    Ann Neurol; 1994 Aug 13; 36(2):157-65. PubMed ID: 8053651
    [Abstract] [Full Text] [Related]

  • 5. Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
    Fu L, Matthews PM, De Stefano N, Worsley KJ, Narayanan S, Francis GS, Antel JP, Wolfson C, Arnold DL.
    Brain; 1998 Jan 13; 121 ( Pt 1)():103-13. PubMed ID: 9549491
    [Abstract] [Full Text] [Related]

  • 6. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
    Sijens PE, Mostert JP, Oudkerk M, De Keyser J.
    Eur Radiol; 2006 Feb 13; 16(2):489-95. PubMed ID: 16028056
    [Abstract] [Full Text] [Related]

  • 7. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S, Francis SJ, Sled JG, Santos AC, Antel S, Levesque I, Brass S, Lapierre Y, Sappey-Marinier D, Pike GB, Arnold DL.
    Neuroimage; 2006 Jan 15; 29(2):637-42. PubMed ID: 16126413
    [Abstract] [Full Text] [Related]

  • 8. 1H MRSI of normal appearing white matter in multiple sclerosis.
    Rooney WD, Goodkin DE, Schuff N, Meyerhoff DJ, Norman D, Weiner MW.
    Mult Scler; 1997 Aug 15; 3(4):231-7. PubMed ID: 9372505
    [Abstract] [Full Text] [Related]

  • 9. Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging.
    Sun J, Song H, Yang Y, Zhang K, Gao X, Li X, Ni L, Lin P, Niu C.
    Medicine (Baltimore); 2017 Apr 15; 96(14):e6534. PubMed ID: 28383419
    [Abstract] [Full Text] [Related]

  • 10. Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy.
    Schocke MF, Berger T, Felber SR, Wolf C, Deisenhammer F, Kremser C, Seppi K, Aichner FT.
    Neuroimage; 2003 Oct 15; 20(2):1253-63. PubMed ID: 14568494
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of normal appearing white matter in multiple sclerosis: comparison of diffusion magnetic resonance, magnetization transfer imaging and multivoxel magnetic resonance spectroscopy findings with expanded disability status scale.
    Anik Y, Demirci A, Efendi H, Bulut SS, Celebi I, Komsuoglu S.
    Clin Neuroradiol; 2011 Nov 15; 21(4):207-15. PubMed ID: 21847666
    [Abstract] [Full Text] [Related]

  • 12. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
    Simone IL, Tortorella C, Federico F, Liguori M, Lucivero V, Giannini P, Carrara D, Bellacosa A, Livrea P.
    J Neurol Sci; 2001 Jan 01; 182(2):143-50. PubMed ID: 11137520
    [Abstract] [Full Text] [Related]

  • 13. Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis.
    Cucurella MG, Rovira A, Río J, Pedraza S, Tintoré MM, Montalbán X, Alonso J.
    NMR Biomed; 2000 Apr 01; 13(2):57-63. PubMed ID: 10797633
    [Abstract] [Full Text] [Related]

  • 14. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis.
    Tartaglia MC, Narayanan S, De Stefano N, Arnaoutelis R, Antel SB, Francis SJ, Santos AC, Lapierre Y, Arnold DL.
    J Neurol; 2002 Oct 01; 249(10):1382-90. PubMed ID: 12382153
    [Abstract] [Full Text] [Related]

  • 15. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    He J, Inglese M, Li BS, Babb JS, Grossman RI, Gonen O.
    Radiology; 2005 Jan 01; 234(1):211-7. PubMed ID: 15528260
    [Abstract] [Full Text] [Related]

  • 16. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS.
    Suhy J, Rooney WD, Goodkin DE, Capizzano AA, Soher BJ, Maudsley AA, Waubant E, Andersson PB, Weiner MW.
    Mult Scler; 2000 Jun 01; 6(3):148-55. PubMed ID: 10871825
    [Abstract] [Full Text] [Related]

  • 17. Spectroscopic imaging of radiation-induced effects in the white matter of glioma patients.
    Virta A, Patronas N, Raman R, Dwyer A, Barnett A, Bonavita S, Tedeschi G, Lundbom N.
    Magn Reson Imaging; 2000 Sep 01; 18(7):851-7. PubMed ID: 11027879
    [Abstract] [Full Text] [Related]

  • 18. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
    Oh J, Pelletier D, Nelson SJ.
    Arch Neurol; 2004 Jul 01; 61(7):1081-6. PubMed ID: 15262739
    [Abstract] [Full Text] [Related]

  • 19. Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
    Stromillo ML, Giorgio A, Rossi F, Battaglini M, Hakiki B, Malentacchi G, Santangelo M, Gasperini C, Bartolozzi ML, Portaccio E, Amato MP, De Stefano N.
    Neurology; 2013 Jun 04; 80(23):2090-4. PubMed ID: 23635962
    [Abstract] [Full Text] [Related]

  • 20. Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.
    Aboul-Enein F, Krssák M, Höftberger R, Prayer D, Kristoferitsch W.
    PLoS One; 2010 Jul 20; 5(7):e11625. PubMed ID: 20652023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.